Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,031 public trials 2,028 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Active, Not Recruiting

Mature B-Cell Lymphoma And Leukemia Study III

NCT01046825

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Rady Children's Hospital San Diego San Diego, California, United States
  • St. Jude Children's Research Hospital Memphis, Tennessee, United States
  • Children's Cancer Hospital Cairo, Egypt
  • National University Health System Singapore
View Trial Details
Active, Not Recruiting

Precision-T: A Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

NCT04013685

Conditions
Acute Leukemia, Acute Lymphoid Leukemia, Acute Myeloid Leukemia, +31 more
Locations
  • City of Hope Duarte, California, United States
  • Ronald Reagan UCLA Medical Center Los Angeles, California, United States
  • UC Davis Sacramento, California, United States
  • Stanford Health Care Stanford, California, United States
View all 21 locations
View Trial Details
Active, Not Recruiting

A Study of BR Alone Versus in Combination With Acalabrutinib in Subjects With Previously Untreated MCL

NCT02972840

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Research Site Tucson, Arizona, United States
  • Research Site Downey, California, United States
  • Research Site Santa Monica, California, United States
  • Research Site New Haven, Connecticut, United States
View all 228 locations
View Trial Details
Active, Not Recruiting

A Study of Acalabrutinib Plus Venetoclax and Rituximab in Participants With Treatment Naïve Mantle Cell Lymphoma

NCT05951959

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Research Site Hackensack, New Jersey, United States
  • Research Site Stony Brook, New York, United States
  • Research Site Cleveland, Ohio, United States
  • Research Site Philadelphia, Pennsylvania, United States
View all 29 locations
View Trial Details
Active, Not Recruiting

COMbination Regimens in MM Post AHCT to elimiNate MRD Utilizing IbERdomide

NCT05434689

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Ohio State University Medical College Columbus, Ohio, United States
  • Oregon Health and Science University Portland, Oregon, United States
  • University of Wisconsin Madison, Wisconsin, United States
View Trial Details
Active, Not Recruiting

Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in Pediatric PID Patients (KIDCARES10)

NCT04944979

Conditions
Agammaglobulinemia, Blood Protein Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +9 more
Locations
  • Benioff Children's Hospital - Mission Bay San Francisco, California, United States
  • IMMUNOe Health and Research Centers Centennial, Colorado, United States
  • Johns Hopkins All Children's Hospital St. Petersburg, Florida, United States
  • Velocity Clinical Research - MedPharmics - Lafayette Lafayette, Louisiana, United States
View all 21 locations
View Trial Details

Related conditions